Page last updated: 2024-12-08
isopropyl-9h-thioxanthen-9-one
Description
Research Excerpts
Clinical Trials
Roles
Classes
Pathways
Study Profile
Bioassays
Related Drugs
Related Conditions
Protein Interactions
Research Growth
Market Indicators
Description
isopropyl-9H-thioxanthen-9-one: structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
Cross-References
ID Source | ID |
---|---|
PubMed CID | 158403 |
SCHEMBL ID | 108905 |
MeSH ID | M0508095 |
Synonyms (29)
Synonym |
---|
AC-13340 |
83846-86-0 |
einecs 281-065-4 |
4-propan-2-ylthioxanthen-9-one |
4-isopropylthioxanthone |
isopropyl-9h-thioxanthen-9-one |
4-isopropyl-9-thioxanthone |
unii-paf3cw7tj8 |
4-isopropyl-9h-thioxanthen-9-one |
paf3cw7tj8 , |
9h-thioxanthen-9-one, 4-(1-methylethyl)- |
AKOS015961146 |
4-isopropyl-thioxanthene-9-one |
9h-thioxanthen-9-one,4-(1-methylethyl)- |
SCHEMBL108905 |
IKVYHNPVKUNCJM-UHFFFAOYSA-N |
4-isopropylthioxanthone, analytical standard |
AS-55091 |
4-isopropyl-thioxanthen-9-one |
FT-0765167 |
CS-0047347 |
DTXSID80868761 |
Q412376 |
mfcd00192247 |
W15680 |
4-isopropylthioxantone |
4-(1-methylethyl)-9h-thioxanthen-9-one; 4-(1-methylethyl)-9h-thioxanthen-9-one; 4-isopropyl-9-thioxanthone; 4-isopropyl-9h-thioxanthen-9-one; 4-isopropylthioxanthone |
4-(1-methylethyl)-9h-thioxanthen-9-one |
4-(propan-2-yl)-9h-thioxanthen-9-one |
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
Research
Studies (9)
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (33.33) | 29.6817 |
2010's | 5 (55.56) | 24.3611 |
2020's | 1 (11.11) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Market Indicators
Research Demand Index: 12.22
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| This Compound (12.22) All Compounds (24.57) |
Study Types
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 0 (0.00%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 9 (100.00%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |